Ayesha Ahmed
Clinical Assistant Professor, Pharmaceutical Sciences 509-368-6667 PBS 403A Spokane

Education

  • PhD in Toxicology, Hamdard University, India
  • MSc in Toxicology, Hamdard University, India
  • BSc in Biochemistry, AMU, India

Additional Training

IRB application processing for human subject research, Office of Research Assurance, Washington State University, Pullman, Washington

Clinical research associate program and good clinical practice (GCP) certification, Kriger Research International Training Institute, Toronto, Canada

Postdoctoral and other Fellowships

Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan

Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan

Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio

Department of Medicine, Division of Rheumatic Diseases, Case Western Reserve University, Cleveland, Ohio

Ad Hoc Reviewer

  • Human and Experimental Toxicology
  • British Journal of Pharmacology
  • Annals of the Rheumatic Diseases
  • Mediators of Inflammation
  • Journal of Functional Foods and Health

Memberships

  • Society of Toxicology
  • Women in Toxicology, specific interest group
  • Pacific Northwest Association of Toxicologists
  • American Association of Colleges of Pharmacy
  • Research Electronic Data Capture (REDCap), administrator for the WSU College of Pharmacy

Teaching

Clinical assistant professor in the Pharmaceutical Sciences department.

Additional information

Ahmed is a toxicologist with interest in acute toxicity, dermal toxicity, reproductive toxicity, mutagenicity, carcinogenicity, and metal-induced toxicity with emphasis on free radical mediated-oxidative stress and tissue injury.

Prior to WSU Ahmed worked as a clinical research consultant at ADS Biotechnology in Toledo, Ohio.

Service at Washington State University College of Pharmacy

Safety committee chair, 2015 – present
Admission committee member, 2015 – present
Assessment committee member, 2015 – present
Accreditation compliance committee member, 2015 – present

Selected Publications

Ahmed S., Riegsecker S., Beamer M., Rahman A., Bellini J.V., Bhansali P., Tillekeratne L.M. (2013) Largazole, a class I histone deacetylase inhibitor, enhances TNF-α-induced ICAM-1 and VCAM-1 expression in rheumatoid arthritis synovial fibroblasts. Toxicology and Applied Pharmacology 270(2):87-96.

Jones B.A., Riegsecker S., Rahman A., Beamer M., Aboualaiwi W., Khuder S.A., Ahmed S. (2013) Role of ADAM-17, p38 MAPK, cathepsins, and the proteasome pathway in the synthesis and shedding of fractalkine/CX₃CL1 in rheumatoid arthritis. Arthritis & Rheumatology 65(11):2814-25.

Mancuso P, Rahman A, Hershey S.D., Dandu L, Nibbelink K.A., Simpson R.U. (2008) 1,25-Dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin. Journal of Cardiovascular Pharmacology 51(6):559-64.

Updated 05/19/2016